Claude Capron

Gif-sur-yvette, 91190, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology.

Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology.

Journal: Current oncology reports

Published: December 06, 2025

Role of the Wnt5A pathway in resistance to immune checkpoint inhibitors in advanced Non-Small Cell Lung Cancer.

Role of the Wnt5A pathway in resistance to immune checkpoint inhibitors in advanced Non-Small Cell Lung Cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: October 29, 2025

Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: September 05, 2024

Combined coagulation and inflammation markers as predictors of venous thrombo-embolism and death in COVID-19.

Combined coagulation and inflammation markers as predictors of venous thrombo-embolism and death in COVID-19.

Journal: Frontiers in medicine

Published: March 11, 2024

Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma.

Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma.

Journal: Pharmaceutics

Published: January 17, 2024

Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 23, 2023

Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinoma.

Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinoma.

Journal: Frontiers in immunology

Published: August 03, 2023

HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes.

HIV-1 inhibits IFITM3 expression to promote the infection of megakaryocytes.

Journal: Journal of molecular cell biology

Published: July 31, 2023

Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases.

Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases.

Journal: Frontiers in immunology

Published: February 27, 2023

FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.

FFCD 1709-SIRTCI phase II trial: Selective internal radiation therapy plus Xelox, Bevacizumab and Atezolizumab in liver-dominant metastatic colorectal cancer.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: February 06, 2022

Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19.

Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19.

Journal: Cellular and molecular life sciences : CMLS

Published: January 15, 2022

Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.

Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.

Journal: Frontiers in immunology

Published: December 23, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026